Naseem Zojwalla Biography and Net Worth

Naseem Zojwalla, M.D., joined Olema Oncology as Chief Medical Officer in January 2022, bringing more than 15 years of experience in oncology and clinical development within both the biopharmaceutical industry and academia. Prior to joining Olema, Dr. Zojwalla served as Vice President of Clinical Development at Turning Point Therapeutics and earlier at Peloton Therapeutics (acquired by Merck) where she headed clinical development and strategy leading to the first-in-class approval of Welireg^® (belzutifan) for the treatment of VHL disease.

Earlier in her career, she held roles of increasing responsibility leading clinical programs at multiple oncology-focused companies, including Onyx Pharmaceuticals, ImClone Systems, and Eisai Medical Research. A hematologist/oncologist by training, Dr. Zojwalla was previously an assistant clinical professor of medicine at Columbia University Medical Center. She received her Bachelor of Science degree from Stanford University and her M.D. from Temple University School of Medicine and completed her hematology/oncology fellowship training at Columbia University Medical Center.

What is Naseem Zojwalla's net worth?

The estimated net worth of Naseem Zojwalla is at least $1.04 million as of November 21st, 2023. Dr. Zojwalla owns 37,759 shares of Olema Pharmaceuticals stock worth more than $1,043,659 as of December 4th. This net worth approximation does not reflect any other assets that Dr. Zojwalla may own. Additionally, Dr. Zojwalla receives a salary of $753,370.00 as Chief Medical Officer at Olema Pharmaceuticals. Learn More about Naseem Zojwalla's net worth.

How old is Naseem Zojwalla?

Dr. Zojwalla is currently 51 years old. There are 4 older executives and no younger executives at Olema Pharmaceuticals. The oldest executive at Olema Pharmaceuticals is Dr. David C. Myles Ph.D., Chief Discovery & Non-Clinical Development Officer, who is 61 years old. Learn More on Naseem Zojwalla's age.

What is Naseem Zojwalla's salary?

As the Chief Medical Officer of Olema Pharmaceuticals, Inc., Dr. Zojwalla earns $753,370.00 per year. There are 2 executives that earn more than Dr. Zojwalla. The highest earning executive at Olema Pharmaceuticals is Dr. Sean P. Bohen M.D., Ph.D., President, CEO & Director, who commands a salary of $1,150,000.00 per year. Learn More on Naseem Zojwalla's salary.

How do I contact Naseem Zojwalla?

The corporate mailing address for Dr. Zojwalla and other Olema Pharmaceuticals executives is 512 2ND STREET 4TH FLOOR, SAN FRANCISCO CA, 94107. Olema Pharmaceuticals can also be reached via phone at 650-243-5555 and via email at [email protected]. Learn More on Naseem Zojwalla's contact information.

Has Naseem Zojwalla been buying or selling shares of Olema Pharmaceuticals?

Naseem Zojwalla has not been actively trading shares of Olema Pharmaceuticals within the last three months. Most recently, Naseem Zojwalla sold 7,461 shares of the business's stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $14.84, for a transaction totalling $110,721.24. Following the completion of the sale, the insider now directly owns 37,759 shares of the company's stock, valued at $560,343.56. Learn More on Naseem Zojwalla's trading history.

Who are Olema Pharmaceuticals' active insiders?

Olema Pharmaceuticals' insider roster includes Sean Bohen (CEO), Cyrus Harmon (CTO), Kinney Horn (Insider), David Myles (Chief Discovery and Non-Clinical Development Officer), and Naseem Zojwalla (Chief Medical Officer). Learn More on Olema Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Olema Pharmaceuticals?

During the last twelve months, Olema Pharmaceuticals insiders bought shares 1 times. They purchased a total of 300,000 shares worth more than $1,728,000.00. During the last twelve months, insiders at the sold shares 8 times. They sold a total of 798,797 shares worth more than $5,619,449.23. The most recent insider tranaction occured on September, 18th when Director Cyrus Harmon sold 10,000 shares worth more than $83,300.00. Insiders at Olema Pharmaceuticals own 16.4% of the company. Learn More about insider trades at Olema Pharmaceuticals.

Information on this page was last updated on 9/18/2025.